Your browser doesn't support javascript.
loading
Establishment of Patient-Derived Gastric Cancer Organoid Model From Tissue Obtained by Endoscopic Biopsies.
Song, Hana; Park, Jae Yong; Kim, Ju-Hee; Shin, Tae-Seop; Hong, Soon Auck; Huda, Md Nazmul; Kim, Beom Jin; Kim, Jae Gyu.
Afiliação
  • Song H; Laboratory of Gastrointestinal Mucosal Immunology, Chung-Ang University College of Medicine, Seoul, Korea.
  • Park JY; Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea.
  • Kim JH; Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea.
  • Shin TS; Laboratory of Gastrointestinal Mucosal Immunology, Chung-Ang University College of Medicine, Seoul, Korea.
  • Hong SA; Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea.
  • Huda MN; Institute of MD Healthcare Inc., Seoul, Korea.
  • Kim BJ; Department of Pathology, Chung-Ang University College of Medicine, Seoul, Korea.
  • Kim JG; Laboratory of Gastrointestinal Mucosal Immunology, Chung-Ang University College of Medicine, Seoul, Korea.
J Korean Med Sci ; 37(28): e220, 2022 Jul 18.
Article em En | MEDLINE | ID: mdl-35851862
ABSTRACT
Cancer organoids are three-dimensional mini-organ analogues derived from cancer tissues and have been proposed as models capable of simulating the structure and function of human organs and tissues in vitro. We sought to establish gastric cancer patient-derived organoids (PDOs) from tissues obtained by endoscopic biopsies. Gastric cancer-PDOs were successfully established and cultured from cancer tissues with gastric adenocarcinoma by endoscopic biopsies. To confirm that gastric cancer-PDOs were derived from cancer tissue, the consistency of the original cancer tissue was assessed by histopathological examination. As a result, it was confirmed that the shape and internal structure of gastric cancer-PDO were derived from the original gastric cancer cells, and the tumor specificity of gastric cancer-PDO was confirmed through Periodic acid-Schiff (PAS) and polyclonal carcinoembryonic antigen antibody staining. These results demonstrate that gastric cancer-PDO models show the characteristics of primary tumors and have potential for drug screening and providing a personalized medicine platform.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Adenocarcinoma Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Adenocarcinoma Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article